Dermatology Times Newsletter

To view this email as a web page, click here.

Skin cancer synopsis

Melanoma staging updates

Dermatologists should be aware that the American Joint Committee on Cancer (AJCC) 8th Edition Melanoma Staging System contains several revisions.

Learn more.

Skin cancer screenings targeting "right" people

About one third of people who received free skin cancer screenings from the AAD's SPOTme program in 2009 and 2010 indicated they had recently seen a change.

Learn more.

Join our Reader Reactor Panel

We are inviting members of our community to join our Reader Reactor Panel. This select group of individuals will help our brand keep the pulse on important issues facing you and your colleagues today.

Take the short survey now!

JOB OPPORTUNITIES

AZ - Integrated Dermatology

CO - Integrated Dermatology

CO - Leavitt Management Group

CT - Integrated Dermatology

District of Columbia - Integrated Dermatology

FL - Eye Associates

FL - Integrated Dermatology

FL - Leavitt Management Group

GA - Leavitt Management Group

IL - Integrated Dermatology

IA - Integrated Dermatology

LA - Integrated Dermatology

MA - Integrated Dermatology

MA - Reliant Medical Group

MD - Integrated Dermatology

MI - Leavitt Management Group

National - Integrated Dermatology

National - Leavitt Management Group

NC - Integrated Dermatology

NY - Integrated Dermatology

NY - Company Confidential

OH - Leavitt Management Group

OR - Cynthia Dreyer MD

PA - Leavitt Management Group

PA - Milton S Hershey Medical Center

TX - Snyder Dermatology

VA - Integrated Dermatology

WI - Gundersen Lutheran Health System

Are You Treating a Marketing Misdiagnosis?

If you're spending money chasing new business because you think you can't generate enough repeat business from existing patients, that's a marketing misdiagnosis. eRelevance can help—less work, lower cost, better results.

Learn more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT